These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Drug development. Lupus drug company asks FDA for second chance. Couzin J Science; 2005 Feb; 307(5711):835. PubMed ID: 15705822 [No Abstract] [Full Text] [Related]
9. [Methods for formulating recommendations for clinical practice]. Dosquet P; Matillon Y J Radiol; 1995 Nov; 76(11):1004-6. PubMed ID: 8594173 [No Abstract] [Full Text] [Related]
10. Two new drugs for homozygous familial hyperchelesterolemia. Med Lett Drugs Ther; 2013 Apr; 55(1413):25-7. PubMed ID: 23545581 [No Abstract] [Full Text] [Related]
11. Therapeutic applications of oligonucleotides. Crooke ST Biotechnology (N Y); 1992 Aug; 10(8):882-6. PubMed ID: 1280444 [TBL] [Abstract][Full Text] [Related]
13. Practice guidelines and practical judgement: the role of mega-trials, meta-analysis and consensus. Charlton BG Br J Gen Pract; 1994 Jul; 44(384):290-1. PubMed ID: 8068372 [No Abstract] [Full Text] [Related]
15. Strategies for designing clinical trials for oligonucleotide therapeutics. Wacheck V Drug Discov Today; 2004 Nov; 9(21):918-23. PubMed ID: 15501726 [TBL] [Abstract][Full Text] [Related]
16. Online consensus conferences for clinical guidelines development - a survey among participants from the International Guidelines for the Treatment of Actinic Keratosis. Werner RN; Jacobs A; Rosumeck S; Nast A J Eval Clin Pract; 2014 Dec; 20(6):853-6. PubMed ID: 24799003 [TBL] [Abstract][Full Text] [Related]
17. Lack of compliance of European Public Assessment Reports to guidelines for paediatric drug development before the introduction of paediatric investigation plans. Piana C; Kliphuis E; Della Pasqua O Clin Trials; 2013 Apr; 10(2):269-79. PubMed ID: 23335676 [TBL] [Abstract][Full Text] [Related]